OAR 332-026-0020
Approved Legend Drugs For Neonatal Use

An LDM may administer the following legend drugs as approved by the Board for neonatal use:
(1) Eye Prophylaxis for disease of the newborn is limited to Erythromycin Ophthalmic (0.5%) Ointment (Ilotycin, AK-Mycin and generics).
(2) Prophylaxis for hemorrhagic disease of the newborn for oral use is limited to Mephyton.
(3) Prophylaxis for hemorrhagic disease of the newborn for intramuscular injection includes:
(a) AquaMephyton; and
(b) Konakion.
(4) Resuscitation is limited to medical oxygen.

Source: Rule 332-026-0020 — Approved Legend Drugs For Neonatal Use, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=332-026-0020.

Last Updated

Jun. 8, 2021

Rule 332-026-0020’s source at or​.us